货号 | PRD293-10 |
简介 | Supplied as ready-to-use 5 ug protein balls |
别名 | MVCD1; VAS; vascular endothelial growth factor A; Vascular permeability factor; Vasculotropin; VEGFA; VEGF-A; VEGFMGC70609; VPF; VPFvascular endothelial growth factor | 全称 | Vascular Endothelial Growth Factor |
反应种属 | Human |
来源 | Spodoptera frugiperda,Sf 21 (baculovirus)-derived Ala27 - Arg191 |
产品组分 |
供应商 | R&D Systems |
Entrez Gene IDs | 7422 (Human); 22339 (Mouse); 83785 (Rat); 281572 (Bovine); 403802 (Canine); 493845 (Feline); 30682 (Zebrafish) |
内毒素水平 | <0.01 EU per 1 μg of the protein by the LAL method. |
生物活性 | Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. Conn, G. et al. (1990) Proc. Natl. Acad. Sci. USA 87:1323. The ED50 is typically 1.0-6.0 ng/mL. |
溶解方法 | Add ProDot directly to the medium or reconstitute at 100 μg/mL in sterile PBS. Alternatively, reconstitute at 500 μg/mL in sterile 4 mM HCl. |
背景 | VEGF (Vascular endothelial growth factor) is a potent mediator of both angiogenesis and vasculogenesis in the fetus and adult. It is required for regulating the proliferation, migration, and survival of embryonic endothelial cells and during wound healing and the female reproductive cycle in adults. Pathologically, it is involved in tumor development and tumor vascular leakage. VEGF binds to VEGF R1/Flt-1, VEGF R2/Flk-1/KDR, and Neuropilin-1. Multiple forms of VEGF are generated by alternative splicing and proteolysis. |
Accession # | NP_001165097 |
运输条件 | Blue Ice |
N-terminal Sequence Analysis | Ala27 |
预期分子量 | 19.2 (monomer) kDa |
SDS-PAGE | 20-22 kDa, reducing conditions 39-42 kDa, non-reducing conditions |
存放说明 | 4℃ |
纯度 | >97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
参考文献 |
|
1 μg/mL of ProDots® Recombinant Human VEGF165 was resolved by SDS-PAGE with silver staining, under reducing (R) and non-reducing (NR) conditions, showing major bands at 20-22 kDa and 39-42 kDa, respectively. Multiple bands in the gel are due to glycosylation. | |
ProDots®VEGF165 stimulates proliferation in HUVEC human umbilical endothelial cells. The ED50 is typically 1.0-6.0 ng/mL. |